BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3059589)

  • 1. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood.
    Anderson CB; Tyler JD; Sicard GA; Anderman CK; Rodey GE; Etheredge EE
    Transplantation; 1984 Dec; 38(6):664-8. PubMed ID: 6239414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of donor-specific transfusions on renal transplantation in children.
    Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
    Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
    Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategy for donor-specific blood transfusions including a pre- and post transplant role for azathioprine.
    Salvatierra O
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):37-41. PubMed ID: 3201558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
    Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
    Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.